Dietary clofibrate stimulates the formation and size of estradiol-induced breast tumors in female August-Copenhagen Irish (ACI) rats

Toxicology

Volumn 246, Issue 1, 2008, Pages 63-72

  Mesia Vela, Sonia ^a   Sanchez, Rosa I ^a   Roberts, Kathleen G ^a   Reuhl, Kenneth R ^a   Conney, Allan H ^a   Kauffman, Frederick C ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Breast cancer; Clofibrate (2 (4 chlorophenoxy) 2 methyl propanoic acid; Estradiol; ethyl ester)

Indexed keywords

CLOFIBRATE; ESTRADIOL; FATTY ACID; GLUCURONOSYLTRANSFERASE; LIVER ENZYME;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUGUST COPENHAGEN IRISH RAT; BREAST ADENOCARCINOMA; CARCINOGENESIS; CONTROLLED STUDY; ESTERIFICATION; FEMALE; GLUCURONIDATION; HISTOPATHOLOGY; LIVER CYTOSOL; LIVER MICROSOME; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR VOLUME;

ANIMALS; ANTILIPEMIC AGENTS; CLOFIBRATE; DIET; ESTRADIOL; FEMALE; MAMMARY NEOPLASMS, ANIMAL; MICROSOMES, LIVER; NAD(P)H DEHYDROGENASE (QUINONE); RATS; RATS, INBRED ACI;

ANIMALIA; RATTUS;

EID: 40249116627     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2007.12.025     Document Type: Article

References (38)

1. Cavalieri E.L., Li K., Balu N., Saeed M., Devanesan P., Higginbotham S., Zhao J., Gross L.M., and Rogan E.G. Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases. Carcinogenesis 23 (2002) 1071-1077
2. Cavalieri E.L., Stack D.E., Devanesan P.D., Todorovic R., Dwivedy I., Higginbotham S., Johansson S.L., Patil K.D., Gross M.L., Gooden J.K., Ramanathan R., Cerny R.L., and Rogan E.G. Molecular origin of cancer: catechol estrogen-3,4 quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. U.S.A. 99 (1997) 10937-10942
3. Cuendet M., Oteham C.P., Moon R.C., and Pezzuto J.M. Quinone reductase induction as a biomarker for cancer chemoprotection. J. Nat. Prod. 69 (2006) 460-463
4. Dinkova-Kostova A.T., Holtzclaw W.D., and Kensler T.W. The role of Keap1 in cellular protective responses. Chem. Res. Toxicol. 18 (2005) 1779-1791
5. el-Bayoumy K., Ji B.Y., Upadhyaya P., Chae Y.H., Kurtzke C., Rivenson A., Reddy B.S., Amin S., and Hecht S.S. Lack of tumorigenicity of cholesterol epoxides and estrone-3,4-quinone in the rat mammary gland. Cancer Res. 56 (1996) 1970-1973
6. Harvell D.M., Strecker T.E., Tochacek M., Xie B., Pennington K.L., McComb R.D., Roy S.K., and Shull J.D. Rat strain-specific actions of 17 beta-estradiol in the mammary gland: correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 2779-2784
7. Hess R., Staubli W., and Riess W. Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat. Nature 208 (1965) 856-858
8. Hershcopf R.J., Bradlow H.L., and Fishman J. Differential hydroxylations of estrone and estradiol in man. J. Clin. Endocrinol. Metab. 62 (1986) 170-173
9. Larner J.M., and Hochberg R.B. The clearance and metabolism of estradiol-17 esters in the rat. Endocrinology 117 (1985) 1209-1214
10. Larner J.M., Shackleton C.H.L., Roitman E., Schwartz P.E., and Hochberg R.B. Measurement of estradiol-17-esters in human tissues. J. Clin. Endocrinol. Metab. 75 (1992) 195-200
11. Li S.A., Weroha S.J., Tawfik O., and Li J.J. Prevention of solely estrogen-induced mammary tumors by Tamoxifen: evidence for estrogen receptor mediation. J. Endocrinol. 175 2 (2002) 297-305
12. Mesia-Vela S., Sanchez R.I., Reuhl K.R., Conney A.H., and Kauffman F.C. Phenobarbital treatment inhibits the formation of estradiol-dependent mammary tumors in the August-Copenhagen Irish rat. J. Pharmacol. Exp. Ther. 317 2 (2006) 590-597
13. Mesia-Vela S., Sanchez R.I., Reuhl K.R., Conney A.H., and Kauffman F.C. Dietary clofibrate inhibits induction of hepatic antioxidant enzymes by chronic estradiol in female ACI rats. Toxicology 200 2/3 (2004) 103-111
14. Mesia-Vela S., Sanchez R.I., Li J.J., Li S.A., Conney A.H., and Kauffman F.C. Catechol estrogen formation in liver microsomes from female ACI and Sprague-Dawley rats: comparison of 2- and 4-hydroxylation revisited. Carcinogenesis 23 8 (2002) 1369-1372
15. Miilunpohja M., Uphoff A., Somerharju P., Tiitinen A., Wahala K., and Tikkanen M.J. Fatty acid esterification of lipoprotein-associated estrone in human plasma and follicular fluid. J. Steroid Biochem. Mol. Biol. 100 2 (2006) 59-66
16. Montano M.M., Chaplin L.J., Deng H., Mesia-Vela S., Gaikwad N., Zahid M., and Rogan E. Protective roles of quinone reductase and tamoxifen against estrogen-induced mammary tumorigenesis. Oncogene (2006) 1-4
17. Nilakantan V., Apear B.T., and Glauert H.P. Effect of the peroxisome proliferator ciprofibrate on lipid peroxidation and 8-hydroxydeoxyguanosine formation in transgenic mice with elevated hepatic catalase activity. Free Radic. Biol. Med. 24 9 (1998) 1430-1436
18. O'Brien M.L., Twaroski T.P., Cunningham M.L., Glauert H.P., and Spear B.T. Effects of peroxisome proliferators on antioxidant enzymes and antioxidant vitamins in rats and hamsters. Toxicol. Sci. 60 (2001) 271-278
19. Qu B., Li O.T., Wong K.P., Tan T.M., and Halliwell B. Mechanism of clofibrate hepatotoxicity: mitochondrial damage and oxidative stress in hepatocytes. Free Radic. Biol. Med. 31 5 (2001) 659-669
20. Rao M.S., and Reddy J.K. Hepatocarcinogenesis of peroxisome proliferators. Ann. N.Y. Acad. Sci. 804 (1996) 573-587
21. Reddy J.K., and Lalwai N.D. Carcinogenesis by hepatic peroxisome proliferators, evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. Crit. Rev. Toxicol. 12 (1983) 1-58
22. Reddy J.K., Azarnoff D.L., and Hignite C.E. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 283 (1980) 397-398
23. Sanchez R.I., Mesia-Vela S., and Kauffman F.C. Induction of NADP(H) quinone oxidoreductase and glutathione S-transferase activities in livers of female August-Copenhagen Irish rats treated chronically with estradiol: comparison with the Sprague-Dawley rat. J. Steroid Biochem. Mol. Biol. 87 2-3 (2003) 199-206
24. Shah N., Antony T., Haddad S., Amenta P., Shirahata A., Thomas T.J., and Thomas T. Antitumor effects of bis(ethyl)polyamine analogs on mammary tumor development in FVB/NTgN (MMTVneu) transgenic mice. Cancer Lett. 146 1 (1999) 15-23
25. Shull J.D., Spady T.J., Snyder M.C., Johansson S.L., and Pennington K.L. Ovary-intact, but not ovarectomized female ACI rats treated with 17b-estradiol develop mammary carcinomas. Carcinogenesis 15 8 (1997) 1595-1601
26. Spady T.J., Pennington K.L., McComb R.D., and Shull J.D. Genetic bases of estrogen-induced pituitary growth in an intercross between the ACI and Copenhagen rat strains: dominant mendelian inheritance of the ACI phenotype. Endocrinology 140 6 (1999) 2828-2835
27. Stone J.P., Holtzman S., and Shellabarger C.J. Neoplastic responses and correlated plasma prolactin levels in diethylstilbestrol-treated ACI and Spraque-Dawley rats. Cancer Res. 39 (1979) 773-778
28. Suchar L.A., Chang R.L., Rosen R.T., Lech J., and Conney A.H. High-performance liquid chromatography separation of hydroxylated estradiol metabolites: formation of estradiol metabolites by liver microsomes from male and female rats. J. Pharmacol. Exp. Ther. 272 (1995) 197-206
29. Talalay P. A fascination with enzymes: the journey not the arrival matters. J. Biol. Chem. 280 (2005) 28829-28847
30. Thomas P.E., Reick L.M., Ryan D.E., and Levin W. Induction of two immunochemically related rat liver cytochrome P450 isozymes cytochromes P450c and P450d, by structurally diverse xenobiotics. J. Biol. Chem. 258 (1983) 4590-4598
31. Turan V.K., Sanchez R.I., Li J.J., Li S.A., Reuhl K.R., Thomas P.E., Conney A.H., Gallo M.A., Kauffman F.C., and Mesia-Vela S. The effects of steroidal estrogens in ACI rat mammary carcinogenesis: 17beta-estradiol, 2-hydroxyestradiol, 4-hydroxyestradiol, 16alpha-hydroxyestradiol, and 4-hydroxyestrone. J. Endocrinol. 183 1 (2004) 91-99
32. Xu S., Zhu B.T., and Conney A.H. Effect of clofibrate administration on the esterification and deesterification of steroid hormones by liver and extrahepatic tissues in rats. Biochem. Pharmacol. 63 5 (2002) 985-992
33. Xu S., Zhu B.T., Turan V., Rusyn I., Thurman R., Peters J.M., Gonzalez F.J., and Conney A.H. PPARalpha-dependent induction of liver microsomal esterification of estradiol and testosterone by a prototypical peroxisome proliferator. Endocrinology 142 8 (2001) 3554-3557
34. Xu S., Zhu B.T., and Conney A.H. Stimulatory effect of clofibrate and gemfibrozil administration on the formation of fatty acid esters of estradiol by rat liver microsomes. J. Pharmacol. Exp. Ther. 296 (2001) 188-197
35. Xu S., Zhu B.T., Cai M.X., and Conney A.H. Stimulatory effect of clofibrate on the action of estradiol in the mammary gland but not in the uterus of rats. J. Pharmacol. Exp. Ther. 297 1 (2001) 50-56
36. Yeldandi A.V., Rao M.S., and Reddy J.K. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Mutat. Res. 448 2 (2000) 159-177
37. Zhang Y., Kensler T.W., Cho C.G., Posner G.H., and Talalay P. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc. Natl. Acad. Sci U.S.A. 91 (1994) 3147-3150
38. Zielinski J.E., Pahuja S.L., Larner J.M., and Hochberg R.B. Estrogenic action of estriol fatty acid esters. J. Steroid Biochem. Mol. Biol. 38 (1991) 399-405